Let surgical robots move towards non-invasive and incision free targets
Following the multi-port laparoscopic robot MP1000 series and the single-port laparoscopic robot SP1000, the CP1000 is Edge Medical’s third-generation surgical robot, marking a transformative leap from multi-port and single-port technologies to non-invasive innovation. Its advantages include:
• Full Lung Accessibility: Reaches 7th-level bronchi and areas like the upper lung lobes, inaccessible to conventional bronchoscopes.
• Intuitive Operation: Gamepad-style controls paired with real-time path navigation enable proficiency after just 5 procedures.
• Precise Biopsy: Fully visualized biopsy process achieves over 90% diagnostic accuracy when combined with CBCT and R-EBUS.
• Full Lung Accessibility: Reaches 7th-level bronchi and areas like the upper lung lobes, inaccessible to conventional bronchoscopes.
• Intuitive Operation: Gamepad-style controls paired with real-time path navigation enable proficiency after just 5 procedures.
• Precise Biopsy: Fully visualized biopsy process achieves over 90% diagnostic accuracy when combined with CBCT and R-EBUS.
Edge Medical, a pioneering Chinese medical robotics company, has developed a comprehensive suite of minimally invasive surgical robots. Notably, Edge Medical is the first company in China to complete pivotal clinical trials for both multi-port and single-port endoscopic surgical robots, and stands among the few globally to offer a bronchoscopic surgical robot.
Surgripharma is proud to join hands with Edge Medical as their Sole Representative in Sri Lanka, to promote and support the full range of Edge Medical’s advanced robotic surgical platforms. This partnership marks a significant step forward in bringing cutting-edge robotic-assisted surgical technologies to the healthcare sector in Sri Lanka.
